raloxifene hydrochloride has been researched along with Menopause in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (13.85) | 18.2507 |
| 2000's | 38 (58.46) | 29.6817 |
| 2010's | 16 (24.62) | 24.3611 |
| 2020's | 2 (3.08) | 2.80 |
| Authors | Studies |
|---|---|
| Azizian, H; Ebrahimi, MN; Karam, GA; Khaksari, M; Raji-Amirhasani, A; Sepehri, G | 1 |
| Alves, KBF; Araujo-Neto, JT; Carneiro, ALB; Dardes, RCM; Haidar, MA; Souza, FA; Spadella, APC | 1 |
| Gavrilidis, E; Gurvich, C; Hudaib, A; Kulkarni, J; Thomas, N; Worsley, R | 1 |
| Kari, S; Lammintausta, R; Unkila, M; Yatkin, E | 1 |
| Yang, ZD; Yu, J; Zhang, Q | 1 |
| Chandler, J; Denker, AE; Gottesdiener, K; He, W; Lazarus, N; Rosenberg, E; Simon, JA; Wagner, JA | 1 |
| Kalam, A; Talegaonkar, S; Vohora, D | 1 |
| Marsden, J | 1 |
| Ardalan, M; Asadi, A; Molaeefard, M; Noshad, H; Sadreddini, S | 1 |
| Lerman, J; Siseles, N | 1 |
| Capp, E; de Freitas, FM; Edelweiss, MI; Valiati, B; Wender, MC | 1 |
| Blond, B | 1 |
| Domeki, N; Ikeda, S; Kasai, K; Kawagoe, Y; Matsumura, M; Monden, T; Nakatani, Y; Shimizu, H; Yanagi, K | 1 |
| Albiñana, V; Bernabéu, C; Bernabeu-Herrero, ME; Botella, LM; Zarrabeitia, R | 1 |
| Barrett-Connor, E; Collins, P; Grady, D; Kornitzer, M; Mischke, JM; Mosca, L; Schroeder, K; Schroeder, R; Wenger, NK | 1 |
| Furumoto, H; Irahara, M; Kamada, M; Kaneyama, M; Kasai, Y; Kobayashi, A; Kuwahara, A; Maegawa, M; Matsui, S; Matsuzaki, T; Tani, A; Uemura, H; Yamamoto, S; Yasui, T | 1 |
| Lethaby, A; Vollenhoven, B | 1 |
| Palacios, S | 1 |
| He, H; Hu, KQ; Hu, Q; Li, JF; Liu, ZM; Wang, X; Yang, FL | 1 |
| Furuya, T | 1 |
| Dantas, AP; Heras, M; Hermenegildo, C; Novella, S | 1 |
| Eyster, KM; Hansen, KA | 1 |
| Pols, HA; Wittenberg, J | 1 |
| Lopes, P; Trémollières, F | 1 |
| Romero, M | 1 |
| Carbonella, M; Colacurci, N; Fornaro, F; Manzella, D; Paolisso, G | 1 |
| Kahán, Z; Thurzó, L | 1 |
| Cosman, F; Lindsay, R; Mikhail, M; Nieves, J; Richart, RM; Scotti, RJ; Vardy, MD; Zion, M | 1 |
| Crans, G; Greenwald, M; Marcus, R; Muchmore, DB; Parfitt, AM; Weinstein, RS | 1 |
| Keck, E | 1 |
| Kammerer, S | 1 |
| Coppola, A; Di Carlo, C; Di Carlo, R; Esposito, E; Meli, R; Nappi, C; Nasti, A; Pacilio, M; Raso, GM | 1 |
| Boisserie-Lacroix, M; Boutet, G; Trillaud, H | 1 |
| Mijatovic, V; van der Mooren, MJ; Vogelvang, TE | 1 |
| Cheifitz, RL | 1 |
| Geiger, MJ; Wenger, NK | 1 |
| Levo, Y; Pines, A | 1 |
| Col, NF; Matloff, ET; Moyer, A; Shannon, KM | 1 |
| Abaurrea Ortiz, MP; Caballero Carrasco, A; Pérez García, VJ; Rangel Tarifa, MJ | 1 |
| Badimon, JJ; Cardoso, L; Choi, BG; Fuster, V; Ibanez, B; Schaffler, MB; Tunstead, J; Vilahur, G; Viles-Gonzalez, JF; Yadegar, D; Zafar, MU | 1 |
| Nelson, NJ | 1 |
| Runowicz, C | 1 |
| Agnusdei, D | 1 |
| Chlebowski, RT; Collyar, DE; Pfister, DG; Somerfield, MR | 1 |
| Boyce, EG; Parks, SM; Rinaldi, C; Umland, EM | 1 |
| Meunier, PJ; Vignot, E | 1 |
| Eriksen, EF | 1 |
| Ambroggio, S; Biglia, N; Cozzarella, M; Ponzone, R; Roagna, R; Sgro, L; Sismondi, P | 1 |
| Reinders, M | 1 |
| Bryant, M; Clark, L; Garces, A; Rhodin, J; Thomas, T | 1 |
| Mamounas, EP | 1 |
| Grossman, LD | 1 |
| Cyr, M; Di Paolo, T; Landry, M; Morissette, M | 1 |
| Cuzick, J | 1 |
| Moore, HC | 1 |
| Perrone, A; Tinelli, A; Tinelli, FG | 1 |
| Fajardo, ME; Malacara, JM; Nava, LE | 1 |
| Kemner, JE; O'Connor, LJ; Ohsfeldt, RL; Solomon, TE | 1 |
| Walsh, BW | 1 |
| Boyack, M; Chasson, S; Lookinland, S | 1 |
| Cohen, SB; Lidor, AL; Lipitz, S; Mashiach, S; Novikov, I; Rabinovici, J; Seidman, DS | 1 |
| Dominguez, JE; Shortle, B; Warren, MP | 1 |
23 review(s) available for raloxifene hydrochloride and Menopause
| Article | Year |
|---|---|
Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: a systematic review of randomized controlled trials.
Topics: Alzheimer Disease; Cognition; Cognition Disorders; Female; Humans; Memory; Menopause; Mental Health; Raloxifene Hydrochloride; Reproductive Health; Selective Estrogen Receptor Modulators; Sleep | 2013 |
Breast cancer chemoprevention: A service in need of menopause specialist support.
Topics: Breast Neoplasms; Counseling; Female; Humans; Menopause; Patient Education as Topic; Physician's Role; Practice Guidelines as Topic; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Selective Estrogen Receptor Modulators; Tamoxifen; United Kingdom | 2017 |
[Hormone replacement therapy and cardiovascular prevention. Where are we now?].
Topics: Aged; Cardiovascular Diseases; Clinical Trials as Topic; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Myocardial Infarction; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Women's Health | 2008 |
Fibroids (uterine myomatosis, leiomyomas).
Topics: Humans; Leiomyoma; Menopause; Pain; Premenopause; Progestins; Raloxifene Hydrochloride; Regression Analysis; Uterine Neoplasms | 2011 |
[Bone and calcium metabolism in patients with rheumatoid arthritis].
Topics: Animals; Arthritis, Rheumatoid; Bone and Bones; Calcium; Disease Models, Animal; Disease Progression; Estrogen Replacement Therapy; Estrogens; Female; Humans; Inflammation Mediators; Joints; Male; Menopause; Osteoporosis; Pregnancy; Pregnancy Complications; Raloxifene Hydrochloride | 2011 |
[Specific estrogen receptor modulators (SERMs)].
Topics: Adult; Antineoplastic Agents, Hormonal; Bone and Bones; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Endometrium; Estradiol; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Humans; Lipid Metabolism; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Polyunsaturated Alkamides; Postmenopause; Prospective Studies; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors | 2002 |
Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
Topics: Chemistry, Pharmaceutical; Climacteric; Drug Combinations; Drug Compounding; Drug Monitoring; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Medroxyprogesterone Acetate; Menopause; Osteoporosis, Postmenopausal; Patient Care Planning; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators | 2002 |
[Breakthrough in breast cancer chemoprevention].
Topics: Anticarcinogenic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Fenretinide; Genes, BRCA1; Genes, BRCA2; Humans; Insulin-Like Growth Factor I; Menopause; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Time Factors | 2003 |
[Menopausal hormonal therapies: impact on mammographic breast density].
Topics: Breast; Breast Neoplasms; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Mammography; Mass Screening; Menopause; Norpregnenes; Raloxifene Hydrochloride | 2004 |
Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.
Topics: Aging; Animals; Arteriosclerosis; Cardiovascular Diseases; Cardiovascular System; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen | 2004 |
Hormone replacement therapy--differing guidelines.
Topics: Contraindications; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Practice Guidelines as Topic; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Treatment Outcome | 2005 |
Selective estrogen receptor modulators and postmenopausal women's health: the promise for the next millennium.
Topics: Aged; Animals; Bone Density; Cardiovascular System; Estrogen Antagonists; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Middle Aged; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen | 1998 |
Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 6: Executive summary and consensus statement. Proceedings of a conference held at Boar's Head Inn, Charlottesville, Virginia, September 21-23, 1997.
Topics: Breast Neoplasms; Cardiovascular Diseases; Clinical Trials as Topic; Estrogen Antagonists; Estrogens; Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Menopause; Osteoporosis; Phytoestrogens; Piperidines; Plant Preparations; Raloxifene Hydrochloride; Receptors, Estrogen; Survivors | 1999 |
American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
Topics: Anticarcinogenic Agents; Bone Density; Breast Neoplasms; Cardiovascular Diseases; Cataract; Endometrial Neoplasms; Estrogen Antagonists; Expert Testimony; Female; Humans; Incidence; Menopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Tamoxifen | 1999 |
The impact of estrogen replacement therapy and raloxifene on osteoporosis, cardiovascular disease, and gynecologic cancers.
Topics: Aged; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Genital Neoplasms, Female; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride | 1999 |
[Raloxifene].
Topics: Breast Neoplasms; Endometrium; Estrogen Antagonists; Female; Humans; Menopause; Middle Aged; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Uterine Hemorrhage | 2000 |
Breast cancer chemoprevention.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anticarcinogenic Agents; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Double-Blind Method; Endometrial Neoplasms; Estrogen Antagonists; Europe; Female; Humans; Hyperlipidemias; Hysterectomy; Mammary Neoplasms, Experimental; Menopause; Mice; Mice, Nude; Middle Aged; Neoplasms, Second Primary; Neoplastic Syndromes, Hereditary; Osteoporosis; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Estrogen; Risk Factors; Tamoxifen; United States | 2000 |
Future possibilities in the prevention of breast cancer: breast cancer prevention trials.
Topics: Adult; Aged; Anticarcinogenic Agents; Bone Density; Breast Neoplasms; Clinical Trials as Topic; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Forecasting; Hormone Replacement Therapy; Humans; Incidence; Menopause; Meta-Analysis as Topic; Middle Aged; Neoplasm Proteins; Patient Compliance; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Estrogen; Risk; Risk Factors; Tamoxifen; Thromboembolism; Treatment Outcome | 2000 |
[An alternative to postmenopausal Hormone Replacement Therapy? Selective Estrogens Receptors Modulators (SERMs)].
Topics: Adult; Aged; Animals; Bone and Bones; Brain; Breast; Breast Neoplasms; Cardiovascular System; Endometrial Neoplasms; Female; Haplorhini; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Uterus; Vagina | 2001 |
The effects of estrogen and selective estrogen receptor modulators on cardiovascular risk factors.
Topics: Cardiovascular Diseases; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Menopause; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen | 2001 |
Treatment of estrogen deficiency symptoms in women surviving breast cancer.
Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Heart Diseases; Humans; Menopause; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Survivors | 1998 |
Efficacy of raloxifene for treatment of menopause: a systematic review.
Topics: Aged; Bone Density; Endometrium; Female; Heart; Humans; Lipids; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome | 2002 |
Use of alternative therapies in menopause.
Topics: Cardiovascular Diseases; Estrogens; Female; Humans; Hypercholesterolemia; Isoflavones; Lignans; Menopause; Middle Aged; Neoplasms; Osteoporosis, Postmenopausal; Phytotherapy; Plant Preparations; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2002 |
13 trial(s) available for raloxifene hydrochloride and Menopause
| Article | Year |
|---|---|
Effects of Raloxifene Combined with Low-dose Conjugated Estrogen on the Endometrium in Menopausal Women at High Risk for Breast Cancer.
Topics: Breast Neoplasms; Double-Blind Method; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Menopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2021 |
Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status.
Topics: Adult; Cognition; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Postmenopause; Premenopause; Psychiatric Status Rating Scales; Raloxifene Hydrochloride; Retrospective Studies; Schizophrenia; Schizophrenic Psychology; Selective Estrogen Receptor Modulators; Treatment Outcome | 2019 |
Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Ethinyl Estradiol; Female; Humans; Menopause; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vulva | 2013 |
Diary of hot flashes reported upon occurrence: results of a randomized double-blind study of raloxifene, placebo, and paroxetine.
Topics: Adult; Double-Blind Method; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Medical Records; Menopause; Middle Aged; Paroxetine; Raloxifene Hydrochloride; Reproducibility of Results; Selective Estrogen Receptor Modulators; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2014 |
Efficacy of Raloxifen in treatment of fibromyalgia in menopausal women.
Topics: Adult; Aged; Double-Blind Method; Estrogen Antagonists; Female; Fibromyalgia; Humans; Menopause; Middle Aged; Pain Measurement; Raloxifene Hydrochloride; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2008 |
Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial.
Topics: Administration, Cutaneous; Aged; Drug Therapy, Combination; Endometrium; Estradiol; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Patient Satisfaction; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2009 |
Electrocardiograms of menopausal women with coronary heart disease or at increased risk for its occurrence.
Topics: Aged; Coronary Disease; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Menopause; Middle Aged; Prognosis; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators | 2010 |
Endothelial function and menopause: effects of raloxifene administration.
Topics: Adult; Blood Flow Velocity; Brachial Artery; Cholesterol, LDL; Chromans; Double-Blind Method; E-Selectin; Endothelium, Vascular; Female; Humans; Intercellular Adhesion Molecule-1; Menopause; omega-N-Methylarginine; Placebos; Postmenopause; Premenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiobarbituric Acid Reactive Substances; Triglycerides; Vascular Cell Adhesion Molecule-1; Vasodilation | 2003 |
Short-term urogenital effects of raloxifene, tamoxifen, and estrogen.
Topics: Aged; Atrophy; Double-Blind Method; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Middle Aged; Placebos; Raloxifene Hydrochloride; Tamoxifen; Urethra; Uterine Prolapse; Vagina | 2003 |
Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women.
Topics: Aged; Biopsy; Bone and Bones; Bone Density; Bone Remodeling; Double-Blind Method; Estrogen Replacement Therapy; Female; Femur Neck; Humans; Lumbar Vertebrae; Menopause; Middle Aged; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2003 |
[Effects of raloxifene on bone loss and fracture risk in the menopausal woman].
Topics: Aged; Bone Density; Female; Humans; Lipids; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Spinal Fractures | 1999 |
Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens.
Topics: Chromans; Clomiphene; Estrogens; Feedback, Physiological; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Hypoglycemic Agents; Insulin Resistance; Menopause; Metformin; Middle Aged; Obesity; Pregnancy; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Effect of raloxifene on the ovarian circulation in women after menopause.
Topics: Aged; Drug Combinations; Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Ovary; Raloxifene Hydrochloride; Regional Blood Flow; Selective Estrogen Receptor Modulators; Single-Blind Method; Vascular Resistance | 2002 |
29 other study(ies) available for raloxifene hydrochloride and Menopause
| Article | Year |
|---|---|
The effects of alone and combination tamoxifen, raloxifene and estrogen on lipid profile and atherogenic index of ovariectomized type 2 diabetic rats.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Therapy, Combination; Estrogens; Female; Lipids; Menopause; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Streptozocin; Tamoxifen | 2020 |
Effects of raloxifene against letrozole-induced bone loss in chemically-induced model of menopause in mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; Biomarkers; Bone Remodeling; Bone Resorption; Cyclohexenes; Female; Femur; Glycoproteins; Intercellular Signaling Peptides and Proteins; Letrozole; Lumbar Vertebrae; Menopause; Mice; Nitriles; Raloxifene Hydrochloride; Triazoles; Vinyl Compounds | 2017 |
[4/5. Osteoporosis].
Topics: Administration, Oral; Adult; Bone Density Conservation Agents; Calcium; Fractures, Bone; Humans; Menopause; Middle Aged; Osteoporosis; Raloxifene Hydrochloride | 2009 |
Effect of raloxifene on serum lipids for type 2 diabetic menopausal women with or without statin treatment.
Topics: Aged; Bone Density Conservation Agents; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Menopause; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride | 2010 |
Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
Topics: Activin Receptors, Type II; Aged; Antigens, CD; Cell Line; Endoglin; Endothelial Cells; Endothelium, Vascular; Epistaxis; Estrogens; Female; Humans; Menopause; Middle Aged; Prospective Studies; Raloxifene Hydrochloride; Receptors, Cell Surface; Selective Estrogen Receptor Modulators; Telangiectasia, Hereditary Hemorrhagic; Transcription, Genetic | 2010 |
Effects of raloxifene on the production of cytokines in stimulated whole blood in ex vivo and in vitro studies.
Topics: Aged; Bone Density Conservation Agents; Bone Diseases, Metabolic; Cell Survival; Cytokines; Female; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Menopause; Middle Aged; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Time Factors | 2011 |
Selective estrogen receptor modulators: the future in menopausal treatment.
Topics: Female; Forecasting; Humans; Indoles; Menopause; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes | 2011 |
Combination of raloxifene, aspirin and estrogen as novel paradigm of hormone replacement therapy in rabbit model of menopause.
Topics: Animals; Aspirin; Drug Therapy, Combination; Estrogens; Female; Hormone Replacement Therapy; Menopause; Rabbits; Raloxifene Hydrochloride | 2011 |
Effects of estrogen on vascular inflammation: a matter of timing.
Topics: Adult; Aged; Aging; Biomarkers; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Interleukin-6; Menopause; Middle Aged; Raloxifene Hydrochloride; Time Factors; Vasculitis | 2012 |
What happened to WHI: menopausal hormonal therapy in 2012.
Topics: Atrophy; Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Patient Selection; Raloxifene Hydrochloride; Vagina | 2012 |
[CBO guideline 'Osteoporosis' (second revision].
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Bone Density; Calcium, Dietary; Dietary Supplements; Female; Fractures, Bone; Humans; Male; Menopause; Middle Aged; Netherlands; Osteoporosis; Practice Guidelines as Topic; Prevalence; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Sex Factors; Societies, Medical; Vitamin D | 2002 |
[Therapy of postmenopausal osteoporosis].
Topics: Activities of Daily Living; Aged; Calcitonin; Calcium; Diphosphonates; Estrogen Antagonists; Estrogens; Exercise; Female; Fluorides; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vitamin D; Walking | 2003 |
[New prevention strategies against breast cancer and cervical carcinoma. What can you advice to your patients].
Topics: Adolescent; Adult; Age Factors; Anastrozole; Anticarcinogenic Agents; Breast Neoplasms; Celecoxib; Child; Double-Blind Method; Estrogen Antagonists; Female; Germany; Hormone Replacement Therapy; Humans; Hysterectomy; Life Style; Mammography; Menarche; Menopause; Middle Aged; Nitriles; Ovariectomy; Pregnancy; Pyrazoles; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Smoking; Sulfonamides; Tamoxifen; Triazoles; Uterine Cervical Neoplasms | 2003 |
Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats.
Topics: Adaptation, Physiological; Adipose Tissue; Animals; Body Weight; Cholesterol; Estradiol; Estrogen Antagonists; Female; Hypothalamus; Leptin; Menopause; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Leptin | 2004 |
Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene.
Topics: Aged; Anticholesteremic Agents; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus; Estrogen Replacement Therapy; Female; Humans; Hyperlipidemias; Lipids; Menopause; Middle Aged; Patient Selection; Raloxifene Hydrochloride; Risk Factors; Smoking | 2005 |
Why is the RUTH trial so important?
Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Coronary Artery Disease; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride | 2007 |
Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: a framework for personalized risk assessment and counseling.
Topics: Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Decision Making; Endometrial Neoplasms; Estrogen Antagonists; Female; Genetic Counseling; Genetic Predisposition to Disease; Health Knowledge, Attitudes, Practice; Health Status; Humans; Menopause; Middle Aged; Models, Biological; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Tamoxifen | 2007 |
[Review of pharmacological treatment of the menopause].
Topics: Cross-Over Studies; Drug Prescriptions; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Primary Health Care; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Spain | 2007 |
Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model.
Topics: Animals; Atherosclerosis; Chemokine CCL2; Cyclooxygenase 2; Disease Models, Animal; Female; Magnetic Resonance Imaging; Matrix Metalloproteinase 1; Menopause; Osteoporosis; Ovariectomy; Rabbits; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2008 |
Anti-estrogens come of age: a pioneer looks back.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Coronary Disease; Estrogen Antagonists; Female; Humans; Menopause; Osteoporosis, Postmenopausal; Piperidines; Raloxifene Hydrochloride; Tamoxifen; Uterine Neoplasms | 1998 |
A new alternative to estrogen: raloxifene.
Topics: Bone Density; Estrogen Antagonists; Female; Humans; Menopause; Osteoporosis, Postmenopausal; Piperidines; Raloxifene Hydrochloride | 1998 |
Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 5: Selective estrogen receptor modulators and hormone replacement therapy. Proceedings of a conference. Charlottesville, Virginia, USA. September 21-23, 1997.
Topics: Antineoplastic Agents; Bone Density; Breast Neoplasms; Estrogen Antagonists; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; Survivors; Tamoxifen | 1999 |
How to manage the menopause following therapy for breast cancer. is raloxifene a safe alternative?
Topics: Blood Coagulation Disorders; Bone Diseases; Breast Neoplasms; Female; Humans; Lipids; Menopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uterine Diseases | 2000 |
Clarification needed for raloxifene use.
Topics: Contraceptives, Oral; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Raloxifene Hydrochloride | 2000 |
Estrogen and raloxifene activities on amyloid-beta-induced inflammatory reaction.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Estrogen Antagonists; Estrogens; Female; Humans; Inflammation; Male; Menopause; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Sex Factors | 2001 |
Drug information needs clarification.
Topics: Aged; Cardiovascular Diseases; Clinical Trials as Topic; Estrogen Antagonists; Female; Fractures, Bone; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Reproducibility of Results; Risk Factors | 2001 |
Estrogenic activity of tamoxifen and raloxifene on rat brain AMPA receptors.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autoradiography; Binding, Competitive; Brain Chemistry; Estrogen Antagonists; Estrogens; Excitatory Amino Acid Agonists; Female; Frontal Lobe; Menopause; Organ Size; Ovariectomy; Radioligand Assay; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Tamoxifen; Tritium; Uterus | 2001 |
Managing menopause after breast cancer: balancing risks and benefits.
Topics: Adult; Alendronate; Antidepressive Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Calcitonin; Climacteric; Cohort Studies; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Follow-Up Studies; Heart Diseases; Humans; Menopause; Menopause, Premature; Neoplasm Recurrence, Local; Osteoporosis; Pregnancy; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors | 2001 |
Patterns of physician-reported diagnoses for women receiving raloxifene prescriptions.
Topics: Aged; Breast Neoplasms; Climacteric; Drug Approval; Drug Labeling; Drug Utilization Review; Estrogen Antagonists; Female; Humans; Medicine; Menopause; Middle Aged; Osteoporosis; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Specialization; United States | 2001 |